Cell-Free Nucleic Acids
The deficits of mammography and the potential of noninvasive diagnostic testing using circulating miRNA profiles are presented in our first review article. Exosomes are important in the transfer of genetic information. The current knowledge on exosome-associated DNAs and on vesicle-associated DNAs a...
Saved in:
: | |
---|---|
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (248 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993548368204498 |
---|---|
ctrlnum |
(CKB)4100000010163790 (oapen)https://directory.doabooks.org/handle/20.500.12854/42861 (EXLCZ)994100000010163790 |
collection |
bib_alma |
record_format |
marc |
spelling |
Nagy, Bálint auth Cell-Free Nucleic Acids MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (248 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier The deficits of mammography and the potential of noninvasive diagnostic testing using circulating miRNA profiles are presented in our first review article. Exosomes are important in the transfer of genetic information. The current knowledge on exosome-associated DNAs and on vesicle-associated DNAs and their role in pregnancy-related complications is presented in the next article. The major obstacle is the lack of a standardized technique for the isolation and measurement of exosomes. One review has summarized the latest results on cell-free nucleic acids in inflammatory bowel disease (IBD). Despite the extensive research, the etiology and exact pathogenesis are still unclear, although similarity to the cell-free ribonucleic acids (cfRNAs) observed in other autoimmune diseases seems to be relevant in IBD. Liquid biopsy is a useful tool for the differentiation of leiomyomas and sarcomas in the corpus uteri. One manuscript has collected the most important knowledge of mesenchymal uterine tumors and shows the benefits of noninvasive sampling. Microchimerism has also recently become a hot topic. It is discussed in the context of various forms of transplantation and transplantation-related advanced therapies, the available cell-free nucleic acid (cfNA) markers, and the detection platforms that have been introduced. Ovarian cancer is one of the leading serious malignancies among women, with a high incidence of mortality; the introduction of new noninvasive diagnostic markers could help in its early detection and treatment monitoring. Epigenetic regulation is very important during the development of diseases and drug resistance. Methylation changes are important signs during ovarian cancer development, and it seems that the CDH1 gene is a potential candidate for being a noninvasive biomarker in the diagnosis of ovarian cancer. Preeclampsia is a mysterious disease—despite intensive research, the exact details of its development are unknown. It seems that cell-free nucleic acids could serve as biomarkers for the early detection of this disease. Three research papers deal with the prenatal application of cfDNA. Copy number variants (CNVs) are important subjects for the study of human genome variations, as CNVs can contribute to population diversity and human genetic diseases. These are useful in NIPT as a source of population specific data. The reliability of NIPT depends on the accurate estimation of fetal fraction. Improvement in the success rate of in vitro fertilization (IVF) and embryo transfer (ET) is an important goal. The measurement of embryo-specific small noncoding RNAs in culture media could improve the efficiency of ET. English screening single nucleotide polymorphism predictive and preventive approach PTEN cell-free DNAs fetal fraction gestational hypertension RASSF1 CDH1 RT-PCR cfDNA statistical models hematopoietic stem cell transplantation NanoString solid organ transplantation copy number variants sarcomas liquid biopsy obesity fetal DNA neutrophil extracellular traps mammography non-invasive prenatal testing ovarian cancer circulating miRNA pyrosequencing growth retardation preeclampsia gestational diabetes mellitus biomarker inflammatory bowel disease multi-level diagnostics PAX1 population study nuclease activity NETosis omics piRNA cell-free DNA prediction leiomyosarcomas network analysis NGS statistical methods circulating nucleic acids deletion/insertion polymorphism gender differences leiomyomas fetal growth restriction blood plasma exosomes miRNA pregnancy-related complications NIPT genetic marker cell-free nucleic acids extracellular vesicles expression next generation sequencing breast cancer individualized patient profile circulating tumor cells maternal serum screening personalized medicine embryo culture medium C19MC microRNA DNA cell-free RNAs z-score fetal cells microchimerism aging plasma 3-03928-074-0 |
language |
English |
format |
eBook |
author |
Nagy, Bálint |
spellingShingle |
Nagy, Bálint Cell-Free Nucleic Acids |
author_facet |
Nagy, Bálint |
author_variant |
b n bn |
author_sort |
Nagy, Bálint |
title |
Cell-Free Nucleic Acids |
title_full |
Cell-Free Nucleic Acids |
title_fullStr |
Cell-Free Nucleic Acids |
title_full_unstemmed |
Cell-Free Nucleic Acids |
title_auth |
Cell-Free Nucleic Acids |
title_new |
Cell-Free Nucleic Acids |
title_sort |
cell-free nucleic acids |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (248 p.) |
isbn |
3-03928-075-9 3-03928-074-0 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT nagybalint cellfreenucleicacids |
status_str |
n |
ids_txt_mv |
(CKB)4100000010163790 (oapen)https://directory.doabooks.org/handle/20.500.12854/42861 (EXLCZ)994100000010163790 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Cell-Free Nucleic Acids |
_version_ |
1796648759664312321 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05836nam-a2201141z--4500</leader><controlfield tag="001">993548368204498</controlfield><controlfield tag="005">20231214133443.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3-03928-075-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4100000010163790</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/42861</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994100000010163790</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Nagy, Bálint</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Cell-Free Nucleic Acids</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (248 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">The deficits of mammography and the potential of noninvasive diagnostic testing using circulating miRNA profiles are presented in our first review article. Exosomes are important in the transfer of genetic information. The current knowledge on exosome-associated DNAs and on vesicle-associated DNAs and their role in pregnancy-related complications is presented in the next article. The major obstacle is the lack of a standardized technique for the isolation and measurement of exosomes. One review has summarized the latest results on cell-free nucleic acids in inflammatory bowel disease (IBD). Despite the extensive research, the etiology and exact pathogenesis are still unclear, although similarity to the cell-free ribonucleic acids (cfRNAs) observed in other autoimmune diseases seems to be relevant in IBD. Liquid biopsy is a useful tool for the differentiation of leiomyomas and sarcomas in the corpus uteri. One manuscript has collected the most important knowledge of mesenchymal uterine tumors and shows the benefits of noninvasive sampling. Microchimerism has also recently become a hot topic. It is discussed in the context of various forms of transplantation and transplantation-related advanced therapies, the available cell-free nucleic acid (cfNA) markers, and the detection platforms that have been introduced. Ovarian cancer is one of the leading serious malignancies among women, with a high incidence of mortality; the introduction of new noninvasive diagnostic markers could help in its early detection and treatment monitoring. Epigenetic regulation is very important during the development of diseases and drug resistance. Methylation changes are important signs during ovarian cancer development, and it seems that the CDH1 gene is a potential candidate for being a noninvasive biomarker in the diagnosis of ovarian cancer. Preeclampsia is a mysterious disease—despite intensive research, the exact details of its development are unknown. It seems that cell-free nucleic acids could serve as biomarkers for the early detection of this disease. Three research papers deal with the prenatal application of cfDNA. Copy number variants (CNVs) are important subjects for the study of human genome variations, as CNVs can contribute to population diversity and human genetic diseases. These are useful in NIPT as a source of population specific data. The reliability of NIPT depends on the accurate estimation of fetal fraction. Improvement in the success rate of in vitro fertilization (IVF) and embryo transfer (ET) is an important goal. The measurement of embryo-specific small noncoding RNAs in culture media could improve the efficiency of ET.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">single nucleotide polymorphism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">predictive and preventive approach</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PTEN</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell-free DNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fetal fraction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gestational hypertension</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RASSF1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CDH1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RT-PCR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cfDNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">statistical models</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">hematopoietic stem cell transplantation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NanoString</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">solid organ transplantation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">copy number variants</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sarcomas</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">liquid biopsy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">obesity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fetal DNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neutrophil extracellular traps</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mammography</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-invasive prenatal testing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ovarian cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circulating miRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pyrosequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">growth retardation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">preeclampsia</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gestational diabetes mellitus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammatory bowel disease</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">multi-level diagnostics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PAX1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">population study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nuclease activity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NETosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">omics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">piRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell-free DNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prediction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">leiomyosarcomas</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">network analysis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NGS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">statistical methods</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circulating nucleic acids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">deletion/insertion polymorphism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gender differences</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">leiomyomas</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fetal growth restriction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blood plasma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">exosomes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pregnancy-related complications</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NIPT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">genetic marker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell-free nucleic acids</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">extracellular vesicles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">expression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">next generation sequencing</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">breast cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">individualized patient profile</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">circulating tumor cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">maternal serum screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">embryo culture medium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">C19MC microRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cell-free RNAs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">z-score</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fetal cells</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">microchimerism</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aging</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">plasma</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-074-0</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:54:29 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2020-02-22 21:58:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338793020004498&Force_direct=true</subfield><subfield code="Z">5338793020004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338793020004498</subfield></datafield></record></collection> |